deferoxamine has been researched along with Atherogenesis in 6 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, L | 2 |
| Frei, B | 3 |
| Zhang, WJ | 1 |
| Wei, H | 1 |
| Fan, Y | 1 |
| Wang, J | 1 |
| Wei, L | 1 |
| He, B | 1 |
| Wang, C | 1 |
| Wang, B | 1 |
| Satchell, L | 1 |
| Leake, DS | 1 |
| Li, W | 1 |
| Hellsten, A | 1 |
| Xu, LH | 1 |
| Zhuang, DM | 1 |
| Jansson, K | 1 |
| Brunk, UT | 1 |
| Yuan, XM | 1 |
6 other studies available for deferoxamine and Atherogenesis
| Article | Year |
|---|---|
Prolonged exposure to LPS increases iron, heme, and p22phox levels and NADPH oxidase activity in human aortic endothelial cells: inhibition by desferrioxamine.
Topics: Aorta; Atherosclerosis; Cells, Cultured; Deferoxamine; Endothelial Cells; Heme; Humans; Iron; Lipopo | 2009 |
The iron chelator, desferrioxamine, reduces inflammation and atherosclerotic lesion development in experimental mice.
Topics: Animals; Aorta; Apolipoproteins E; Atherosclerosis; Chemokine CCL2; Cholesterol; Deferoxamine; Femal | 2010 |
Iron deficiency activates pro-inflammatory signaling in macrophages and foam cells via the p38 MAPK-NF-κB pathway.
Topics: Acute Coronary Syndrome; Atherosclerosis; Basigin; Cell Line; Deferoxamine; Foam Cells; Gene Express | 2011 |
Oxidation of low-density lipoprotein by iron at lysosomal pH: implications for atherosclerosis.
Topics: alpha-Tocopherol; Atherosclerosis; Chlorides; Deferoxamine; Ferric Compounds; Ferrous Compounds; Hyd | 2012 |
Foam cell death induced by 7beta-hydroxycholesterol is mediated by labile iron-driven oxidative injury: mechanisms underlying induction of ferritin in human atheroma.
Topics: Animals; Apoptosis; Atherosclerosis; Deferoxamine; Ferritins; Foam Cells; Humans; Hydroxycholesterol | 2005 |
Iron chelation inhibits NF-kappaB-mediated adhesion molecule expression by inhibiting p22(phox) protein expression and NADPH oxidase activity.
Topics: Animals; Atherosclerosis; Cell Adhesion Molecules; Cytochrome b Group; Deferoxamine; Female; Gene Ex | 2006 |